Cell Signaling Technology X XMT / XP

XMT Introduction

XMT, an eXceptional Monoclonal Technology from Cell Signaling Technology (CST), enables the development and production of antibodies with eXceptional Performance (XP). This revolutionary and proprietary technology provides us with access to a broad range of antibody-producing B cells unattainable with traditional monoclonal technologies, allowing more comprehensive screening and the identification of XP monoclonal antibodies with:

• eXceptional Specificity - As with all of our antibodies, the antibody is specific to your target of interest, saving you valuable time and resources.
  
  
• eXceptional Sensitivity - The antibody will provide a stronger signal for your target protein in cells and tissues, allowing you to monitor expression of low levels of endogenous proteins, saving you valuable materials.
  
  
• eXceptional Stability and Reproducibility - XMT combined with our stringent quality control ensures maximum lot-to-lot consistency and the most reproducible results.
  
  
• eXceptional Performances - CST’s proprietary technology coupled with our extensive antibody validation and stringent quality control delivers XP™ monoclonal antibodies with eXceptional Performance in the widest range of applications.
  
  

Click here to find more information regarding the case studies of XP monoclonal antibodies.

For the complete list of all XP monoclonal antibodies, click here

Phospho-Histone H3 (Ser10) (D2C8) XP Rabbit mAb #3377 Figure 1. Confocal immunofluorescent analysis of HeLa cells using Phospho-Histone H3 (Ser10) (D2C8) XP Rabbit mAb #3377 (green). Actin filaments have been labeled with DY-554 phalloidin (red). Blue pseudocolor = DRAQ5 #4084 (fluorescent DNA dye).